Chemical stability and human plasma pharmacokinetics of reduced folates.
The in vitro stability and plasma pharmacokinetics of 5,10-methylenetetrahydrofolic acid (CH2FH4), tetrahydrofolic acid (FH4), 5-methyltetrahydrofolic acid (CH3FH4), and 5-formyltetrahydrofolic acid (5-CHOFH4) were studied in view of their potential usefulness in cancer chemotherapy. Analysis of reduced folates was done on a high-performance liquid chromatography (HPLC) system. The high sensitivity of FH4 and CH2FH4 to oxidation can be circumvented by use of high concentrations of the folates, addition of ascorbate, and by thorough exclusion of atmospheric O2. Intravenous injection of 200 mg FH4 or CH2FH4 resulted in average peak concentrations of 69.2 +/- 3.2 nmol/ml and 46.3 +/- 2.6 nmol/ml, respectively. The plasma concentration curves support the concept that these highly oxygen-sensitive reduced folates can be reliably administered as pharmaceuticals to cancer patients through the use of a suitable air-occlusive system for their preparation and administration.
Department of Surgery, Göteborg University, Sweden.
E
E
Odin
G
G
Carlsson
R
R
Frösing
B
B
Gustavsson
C P
CP
Spears
P A
PA
Larsson
D015179:Colorectal Neoplasms / Q000097:blood; D004355:Drug Stability; D005260:Female; D005575:Formyltetrahydrofolates / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics; D006801:Humans; D008297:Male; D010084:Oxidation-Reduction; D013763:Tetrahydrofolates / Q000097:blood / Q000737:chemistry* / Q000493:pharmacokinetics*
D005575:Formyltetrahydrofolates; D013763:Tetrahydrofolates; C013123:5,10-methylenetetrahydrofolic acid; C030371:5,6,7,8-tetrahydrofolic acid